Huma, Alcedis

Huma to provide best-in-class digital clinical trials solutions through landmark acquisition of Alcedis

09.01.2023 - 09:03:07

Huma to provide best-in-class digital clinical trials solutions through landmark acquisition of Alcedis. HUMA Therapeutics Austria Belgium France Italy Netherlands Spain Switzerland Germany United States of America United Kingdom

Acquisition combines award-winning digital health platform with global clinical research expertise acquired over 25 years Creates new and advanced digital solutions across all phases of clinical trials Accelerates patient recruitment and the development of new therapies through end-to-end digital-first research and care discuss the potential of the acquisition.

Financial terms are not disclosed.

About Huma

Huma Therapeutics is a global digital health technology company that advances digital-first care delivery and research to help people live longer, fuller lives.

Huma's award-winning modular platforms are used by more than 3,000 hospitals and clinics, with 1.8+ million active users in healthcare and 650,000+ participants across research. Huma's regulated Software as a Medical Device powers:

remote patient monitoring (RPM) for health systemscompanion apps to support patients through treatment and drug therapiesvirtual clinical trials to accelerate research

Huma's Decentralized and Hybrid Clinical Trial (DCT) platform now includes the clinical expertise of Alcedis GmbH, a global digital first clinical trials company and market-leader for data driven clinical research and technology.

Please visit www.huma.com and follow us on LinkedIn at Huma

Media contacts

Sian Jarvis
Chief Corporate Affairs and Marketing Officer, Huma
sian.jarvis@huma.com

Karen Birmingham PhD
Head of PR & Communications, Huma
karen.birmingham@huma.com

Logo: https://mma.prnewswire.com/media/1427908/Huma_Logo.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/huma-to-provide-best-in-class-digital-clinical-trials-solutions-through-landmark-acquisition-of-alcedis-301715943.html

@ prnewswire.co.uk